Pregled bibliografske jedinice broj: 1282648
Sucralose Targets the Insulin Signaling Pathway in the SH-SY5Y Neuroblastoma Cell Line
Sucralose Targets the Insulin Signaling Pathway in the SH-SY5Y Neuroblastoma Cell Line // Metabolites, 13 (2023), 7; 817, 17 doi:10.3390/metabo13070817 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1282648 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Sucralose Targets the Insulin Signaling Pathway in the SH-SY5Y Neuroblastoma Cell Line
Autori
Čović, Marina:Zjalić, Milorad:Mihajlović, Lovro:Pap, Marianna:Wagner, Jasenka:Mandić, Dario:Debeljak, Željko:Heffer, Marija
Izvornik
Metabolites (2218-1989) 13
(2023), 7;
817, 17
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
non-nutritive sweetener ; insulin signaling ; dopaminergic neurons ; insulin like growth factor 1 receptor ; neurodegeneration
Sažetak
Sucralose is widely used as a non-nutritive sweetener (NNS). However, in order to justify its use as a non-nutritive food additive, sucralose would have to be metabolically neutral. The aim of this study was to examine whether sucralose altered the insulin signaling pathway in an in vitro cell model of Parkinson’s disease (PD)—the dopaminergic differentiated cell line SH-SY5Y. Cells were exposed to sucralose alone and in combination with either insulin or levodopa. Activation of the insulin signaling pathway was assessed by quantifying protein kinase B (AKT) and glycogen synthase kinase 3 (GSK3), as well as the phosphorylated forms of insulin-like growth factor 1 receptor (IGF1-R). Metabolic effects were assayed using MALDI-TOF MS analysis. In the cell viability test, 2 mM sucralose had a negative effect, and levodopa in all combinations had a positive effect. Sucralose treatment alone suppressed GSK3 and IGF1-R phosphorylation in a dose-dependent manner. This treatment also altered the metabolism of fatty acids and amino acids, especially when combined with insulin and levodopa. Suppression of the insulin signaling pathway and sucralose-induced changes in the metabolic profile could underlie a diet-acquired insulin resistance, previously associated with neurodegeneration, or may be an altered response to insulin or levodopa medical therapy.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Interdisciplinarne prirodne znanosti, Biotehnologija, Nutricionizam, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
EK-EFRR-KK.01.1.1.02.0015 - Istraživanje i dijagnostika malignih, infektivnih i rijetkih metaboličkih bolesti temeljena na MALDI TOF tehnologiji (Debeljak, Željko, EK - KK.01.1.1.02) ( CroRIS)
HRZZ-IP-2014-09-2324 - Patofiziološke posljedice promjena sastava lipidnih splavi (RafTuning) (Heffer, Marija, HRZZ - 2014-09) ( CroRIS)
EK-Erasmus+-2018-1-HR01-KA103-046928 - Erasmus+ mobilnost studenata i (ne)nastavnog osoblja – projekti mobilnosti između programskih zemalja (KA103) (Urem, Frane, EK ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek,
Fakultet za dentalnu medicinu i zdravstvo, Osijek
Profili:
Dario Mandić
(autor)
Milorad Zjalić
(autor)
Jasenka Wagner
(autor)
Marija Heffer
(autor)
Marina Čović
(autor)
Željko Debeljak
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus